I have a seminar on the main topic "Pyrexia of Unknown Origin", in which I have to focus on meningitis. So, based on the above PDF from Davidson's textbook, give me details on what meningitis is, its epidemiology, aetiologies, detailed and chronological pathophysiology, clinical manifestations, investigations (from the most important to least important) and its expected outcome, and its management (from the most important to least important.)

Reading File
The user has provided the PDF directly, which contains all the Davidson's textbook content I need. I have all 5 pages of the meningitis section. Let me now compile a comprehensive, well-structured answer directly from the provided PDF content.

Meningitis — Davidson's Principles and Practice of Medicine


1. What Is Meningitis?

Meningitis is acute infection of the meninges — the membranes covering the brain and spinal cord. The characteristic clinical triad is:
  • Pyrexia (fever)
  • Headache
  • Meningism — headache, photophobia, and neck stiffness, sometimes with:
    • Kernig's sign: extension at the knee with the hip joint flexed causes spasm in the hamstring muscles
    • Brudzinski's sign: passive flexion of the neck causes flexion of the hips and knees
Meningitis frequently presents without meningism. Kernig's and Brudzinski's signs are specific but their sensitivity can be as low as 5%. Meningitis should therefore be considered in anyone who presents with fever and headache.
Altered level of consciousness may occur and is more common in older people.

2. Epidemiology

  • Viruses are the most common cause of meningitis globally.
  • Bacterial meningitis — geographical patterns of causative organisms vary and are strongly age-related.
  • In the 'meningitis belt' of sub-Saharan Africa, drought and dust storms (Harmattan winds) are associated with meningococcal outbreaks.
  • Most bacterial causes are normal commensals of the upper respiratory tract; new pathogenic strains are acquired by droplet spread, requiring close contact.
  • Epidemics of meningococcal meningitis occur in cramped living conditions or hot, dry climates.
  • Tuberculosis and cysticercosis may not be prevalent in high-income countries but are common in other regions and occur in returning travellers or immigrants.
  • Fungal meningitis is uncommon and almost exclusively occurs in the immunosuppressed.
  • Streptococcus suis, a rare zoonotic cause, is an important cause in parts of Asia (Vietnam, Thailand) and is associated with porcine contact — >50% of survivors develop some hearing loss.
  • Antibiotic use has reduced bacterial meningitis frequency, but mortality and morbidity remain significant.

Bacterial Causes by Age Group

AgeCommonLess Common
NeonateGram-negative bacilli (E. coli), Group B streptococciListeria monocytogenes
Pre-school childHaemophilus influenzae, N. meningitidis (A/B/C/Y/W), S. pneumoniaeMycobacterium tuberculosis
Older child & adultS. pneumoniae, N. meningitidis (A/B/C/Y/W), M. tuberculosis, H. influenzaeL. monocytogenes, other streptococci, S. aureus (skull fracture)

3. Aetiologies

Infective

Bacteria
  • Streptococcus pneumoniae (pneumococcus)
  • Neisseria meningitidis (meningococcus — serogroups A, B, C, Y, W135)
  • Mycobacterium tuberculosis
  • Haemophilus influenzae
  • Listeria monocytogenes
  • Staphylococcus aureus (skull fracture)
  • Other streptococci including Streptococcus suis
Viruses
  • Enteroviruses (echo, Coxsackie, polio) — most common viral cause
  • Herpes simplex virus type 2 (Mollaret's meningitis)
  • Varicella zoster virus
  • Herpes simplex type 1
  • Epstein–Barr virus
  • Cytomegalovirus
  • Measles, Mumps
  • Lymphocytic choriomeningitis virus, West Nile virus, HIV
Fungi
  • Cryptococcus neoformans (most common fungal cause; strongly associated with HIV)
  • Candida, Histoplasma, Blastomyces, Coccidioides, Sporothrix

Non-infective ('Sterile')

Malignant disease: Breast cancer, bronchogenic cancer, leukaemia, lymphoma
Inflammatory/Autoimmune (may be recurrent):
  • Sarcoidosis
  • Systemic lupus erythematosus (SLE)
  • Behçet's disease

4. Pathophysiology (Chronological)

Bacterial Meningitis

Step 1 — Colonisation of the Nasopharynx The organism (most commonly S. pneumoniae or N. meningitidis) colonises the nasopharynx, typically acquired by droplet spread from a carrier or index case.
Step 2 — Invasion and Bacteraemia The organism invades through the nasopharyngeal mucosa, enters the bloodstream, and causes bacteraemia. Bacterial meningitis is thus usually part of a bacteraemic illness. Alternatively, direct spread may occur from an adjacent focus of infection (ear, skull fracture, or sinus).
Step 3 — Meningeal Invasion and Immune Activation The bacteria cross into the subarachnoid space. This stimulates an immune response, causing the pia–arachnoid membrane to become congested and infiltrated with inflammatory cells.
Step 4 — Pro-inflammatory Cascade Pro-inflammatory immune mediators are released — particularly prominent in S. pneumoniae infection — and are thought to account for the poor prognosis associated with pneumococcal meningitis.
Step 5 — Purulent Exudate Formation Pus forms in layers within the meningeal space, which may later organise to form adhesions.
Step 6 — Complications from Adhesions and Exudate
  • Adhesions may obstruct the free flow of CSF → hydrocephalus
  • They may damage cranial nerves at the base of the brain → hearing loss (a frequent complication)
  • CSF pressure rises rapidly; protein content increases; a cellular reaction develops (type and severity vary with the causative organism)
Step 7 — Vascular Compromise An obliterative endarteritis of the leptomeningeal arteries passing through the meningeal exudate may produce secondary cerebral infarction.

Tuberculous Meningitis

  • Most commonly occurs shortly after a primary TB infection in childhood or as part of miliary tuberculosis.
  • The usual source is a caseous focus in the meninges or brain substance adjacent to the CSF pathway.
  • The brain becomes covered by a greenish, gelatinous exudate especially around the base.
  • Numerous scattered tubercles appear on the meninges.
  • The slower, more insidious nature (onset over 2–8 weeks) distinguishes it from other bacterial meningitides.

Viral Meningitis

  • Results in a benign, self-limiting illness.
  • The acute immune response causes lymphocytic infiltration of the CSF.
  • Unless associated encephalitis occurs, prognosis is excellent.

Fungal Meningitis (Cryptococcus neoformans)

  • Occurs predominantly in the immunosuppressed (HIV infection).
  • Leads to raised intracranial pressure (CSF opening pressure often very raised).
  • CSF findings resemble tuberculous meningitis (lymphocytes, elevated protein, low glucose).

5. Clinical Manifestations

General Features (All Meningitis)

  • Fever and headache — most common presenting features
  • Meningism: neck stiffness, photophobia
  • Kernig's sign; Brudzinski's sign (specific but low sensitivity ~5%)
  • Altered consciousness — more common in older patients

Bacterial Meningitis

  • 90% of patients have any two of: headache, pyrexia, meningism, and altered consciousness
  • Drowsiness, progressing to coma in severe cases
  • Focal neurological signs (later in disease)
  • Seizures — occur in ~25% of patients
  • Rash — in meningococcal meningitis (morbilliform, petechial, or purpuric)
  • Rapid onset obtundation due to cerebral oedema when accompanied by sepsis
Specific associations:
  • Pneumococcal meningitis: accompanying otitis media, pneumonia; more common in older patients, alcoholics, and those with hyposplenism; very purulent CSF; high mortality
  • Meningococcal meningitis: rash (petechial/purpuric), can progress to septicaemia; complications include shock, intravascular coagulation, renal failure, peripheral gangrene, arthritis (septic or reactive), pericarditis
  • Listeria monocytogenes: causes rhombencephalitis (brainstem encephalitis) in immunosuppressed, neonates, older adults, diabetics, alcoholics, and pregnant women
  • Chronic meningococcaemia (rare): weeks/months of recurrent fever, sweating, joint pains, transient rash

Tuberculous Meningitis (onset over 2–8 weeks)

Symptoms: Headache, vomiting, low-grade fever, lassitude, depression, delirium, behaviour changes
Signs: Meningism (may be absent), oculomotor palsies, papilloedema, depression of conscious level, focal hemisphere signs
Staging:
  • Stage I (early): Non-specific symptoms/signs, no alteration of consciousness — complete recovery usual with treatment
  • Stage II (intermediate): Altered consciousness without coma or delirium + minor focal neurological signs
  • Stage III (advanced): Stupor or coma, severe neurological deficits, seizures, or abnormal movements — death or serious neurological deficit in up to 30% even with treatment

Viral Meningitis

  • Occurs mainly in children or young adults
  • Acute onset of headache, irritability and rapid development of meningism
  • Headache is usually the most severe feature
  • High pyrexia possible; focal neurological signs are rare

Fungal Meningitis

  • Atypical presentation: subacute or chronic meningism, fever, headache
  • Symptoms of raised intracranial pressure

6. Investigations (Most to Least Important)

1. Lumbar Puncture (LP) — Most Critical

  • Mandatory unless contraindicated
  • CSF analysis differentiates the cause (Box 28.6 in Davidson's)
  • Contraindications to immediate LP:
    • Signs of severe sepsis or rapidly evolving rash
    • Anticoagulant therapy/known thrombocytopaenia
    • Respiratory or cardiac compromise
    • Focal neurological signs
    • Papilloedema
    • Continuous or uncontrolled seizures
    • GCS ≤ 12
CSF findings by type:
FeatureBacterialViralTuberculousFungal
AppearanceTurbid/purulentClearClear (may clot — 'spider web')Clear
CellsNeutrophils (high)LymphocytesLymphocytes (up to 500×10⁶/L)Lymphocytes (20–200×10⁶/L)
ProteinElevatedUsually normal (may rise)Markedly elevatedElevated
GlucoseLowNormalMarkedly lowLow
  • Gram film and culture: may identify the organism
  • Viral NAAT (nucleic acid amplification test): identifies specific viral cause
  • TB: smear of centrifuged deposit (negative doesn't exclude); culture (takes up to 6 weeks); WHO recommends Xpert MT/RIF Ultra NAAT in addition to smear and culture
  • Fungal: India ink test, cryptococcal PCR, cryptococcal antigen (in CSF and sometimes serum)
  • Note: a bloody tap may complicate CSF findings — if WBC is above normal, treat for bacterial meningitis and disregard the red cell count

2. Blood Cultures — Immediately Essential

  • Must be taken before starting antibiotics if possible
  • May be positive; PCR can identify bacterial DNA on blood for several days after antibiotic treatment has started
  • Meningococcal and pneumococcal PCR on blood

3. CT Brain (Before LP if Contraindicated)

  • Performed to exclude a mass lesion (e.g. cerebral abscess) before LP, to prevent coning
  • Should not delay empirical treatment
  • Brain imaging in TB meningitis may show: hydrocephalus, basal meningeal enhancement on contrast CT/MRI, or intracranial tuberculoma

4. PCR (Blood and CSF)

  • PCR techniques can identify bacterial DNA from blood and CSF for several days after antibiotic treatment has started
  • Meningococcal PCR, pneumococcal PCR
  • Throat swab for enterovirus PCR if viral meningitis is likely
  • Xpert MT/RIF Ultra for TB

5. Full Blood Count, CRP/Procalcitonin, Biochemistry

  • Full blood count, creatinine, electrolytes, glucose, liver function tests, clotting screen
  • Procalcitonin or CRP — useful inflammatory markers
  • Serology sample

6. MRI Brain

  • More sensitive than CT in detecting early abnormalities in encephalitis
  • For TB meningitis: shows basal meningeal enhancement, hydrocephalus, tuberculoma

7. EEG (Viral Encephalitis)

  • Usually abnormal in early viral encephalitis
  • Shows characteristic periodic slow-wave activity in the temporal lobes in herpes simplex encephalitis

7. Expected Outcome (Prognosis)

TypePrognosis
Viral meningitisExcellent — complete recovery is the rule; self-limiting within days
Bacterial meningitis (untreated)~80% mortality
Bacterial meningitis (treated)Significant residual mortality and morbidity remain despite antibiotics
TB meningitis — Stage I (treated)Complete recovery is usual
TB meningitis — Stage II/III (treated)Death or serious neurological deficit in up to 30%; untreated is fatal in weeks
Fungal meningitisComplex management required; raised CSF pressure often requires repeated (sometimes daily) LP

Adverse Prognostic Factors (Bacterial Meningitis):

  • Hypotensive shock
  • Rapidly developing rash
  • Haemorrhagic diathesis
  • Multisystem failure
  • Age over 60 years
  • Presentation with sepsis rather than meningitis (doubles mortality in meningococcal disease)

Common Sequelae:

  • Hearing loss — frequent complication (>50% of S. suis survivors; common in bacterial meningitis)
  • Cranial nerve palsies
  • Hydrocephalus
  • Cognitive impairment
  • Focal neurological deficits
  • Epilepsy

8. Management (Most to Least Important)

Immediate Priorities

1. Resuscitate and Stabilise the Patient

  • Assess GCS within the first hour after arrival
  • Assess need for intensive care (cardiac, respiratory, or renal involvement; CNS depression)
  • Early endotracheal intubation and mechanical ventilation protect the airway and may prevent ARDS in severe cases

2. Blood Cultures + Empirical Antibiotics — Start Within 1 Hour

  • If LP cannot be performed immediately, start empirical antibiotic treatment after blood cultures and within the first hour
  • If predominantly sepsis or rapidly evolving rash: give antibiotics immediately after blood cultures, follow sepsis guidelines, and defer LP

3. Lumbar Puncture (if no contraindication)

  • Perform LP if no contraindication
  • If contraindicated, obtain CT first
  • Note: once stable, LP may still be diagnostically useful even after several days

Empirical Antibiotic Therapy (British Infection Association Guideline 2016)

(when cause is unknown — Box 28.62)
Patient GroupRegimen
Adults < 60 yearsCefotaxime 2 g IV 4× daily or Ceftriaxone 2 g IV twice daily
Suspected penicillin-resistant pneumococcal infectionAs above + Vancomycin 15–20 mg/kg IV twice daily or Rifampicin 600 mg IV/orally twice daily
Adults > 60 years, or Listeria suspected (brainstem signs, immunosuppression, diabetic, alcohol misuser)Cefotaxime/Ceftriaxone + Ampicillin 2 g IV 6× daily or Amoxicillin 2 g IV 6× daily
Adults > 60 years + penicillin resistance in communityAs above (all combined)
Anaphylaxis to β-lactamsChloramphenicol 25 mg/kg IV 4× daily + Vancomycin 15–20 mg/kg IV twice daily (if >60: add co-trimoxazole 10–20 mg/kg)

Targeted Antibiotic Therapy (when organism is known — Box 28.63)

PathogenRegimen of ChoiceDuration
N. meningitidisCefotaxime 2 g IV 4× daily or Ceftriaxone 2 g IV twice daily5–7 days
S. pneumoniae (β-lactam sensitive)Cefotaxime 2 g IV 4× daily or Ceftriaxone 2 g IV twice daily10–14 days
S. pneumoniae (β-lactam resistant)As sensitive + Vancomycin 15–20 mg/kg IV twice daily or Rifampicin 600 mg IV twice daily14 days
H. influenzaeCefotaxime 2 g IV 4× daily10 days
L. monocytogenesAmoxicillin 2 g IV 6× daily21 days
S. suisCefotaxime 2 g IV 4× daily10–14 days
Duration guide: pneumococcal 10–14 days; meningococcal ~7 days; Listeria 21 days. Local guidance should always be sought.

4. Adjunctive Dexamethasone

  • Dexamethasone 10 mg IV 4× daily for 2–4 days
  • Useful in reducing hearing loss and neurological sequelae in both children and adults in high-income countries
  • Evidence does not support its use in lower-income countries or where there are high rates of untreated HIV

5. Management of Tuberculous Meningitis

  • Start anti-TB chemotherapy (including pyrazinamide) as soon as diagnosis is made or strongly suspected — do not wait for culture confirmation (results may take up to 6 weeks)
  • Add glucocorticoids early — improves mortality (though not focal neurological damage), regardless of HIV status
  • Surgical ventricular drainage may be needed if obstructive hydrocephalus develops
  • Skilled nursing, adequate hydration, and nutrition essential during acute phase

6. Management of Fungal Meningitis

  • Antifungal therapy (treatment discussed in specialist chapter p. 363)
  • Treatment of raised CSF pressure may be complex and frequent — sometimes daily lumbar punctures are required

7. Prevention of Meningococcal Infection (Chemoprophylaxis)

Close contacts of meningococcal cases should receive:
  • Single dose of ciprofloxacin (preferred)
  • Rifampicin for 2 days (alternative if unable to take ciprofloxacin)
Close contacts warranting chemoprophylaxis include:
  • Household contacts (ate/slept in same dwelling within 7 days)
  • Child-care and nursery-school contacts
  • Persons having contact with patient's oral secretions within 7 days (kissing, shared toothbrush/utensils, mouth-to-mouth resuscitation, unprotected endotracheal intubation)
  • Aircraft contacts seated next to patient for >8 hours
Vaccines are available for most meningococcal subgroups.

8. Management of Viral Meningitis

  • No specific treatment; condition is usually benign and self-limiting
  • Treat symptomatically in a quiet environment
  • Recovery usually occurs within days

Source: Davidson's Principles and Practice of Medicine, Chapter 28 — Infections of the Nervous System, pp. 1171–1175
This is a shared conversation. Sign in to Orris to start your own chat.